AI is where the data is Logo (WIPO, 12/09/2021)
WIPOProtect this trademark from copycats!
With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.
The International trademark AI is where the data is was filed as Word mark on 12/09/2021 at the World Intellectual Property Organization.
| Trademark form | Word mark |
| File reference | 1646138 |
| Register number | 018495423 |
| Countries | 
|
| Base trademark |
No. 018495423,
December 2, 2021
|
| Application date | December 9, 2021 |
| Expiration date | December 9, 2031 |
Trademark owner
Paul-Ehrlich-Strasse 15
72076 Tübingen
DE
72076 Tübingen
DE
Trademark representatives
Alstertor 21
20095 Hamburg
DE
goods and services
09
Bioinformatics software; graphical user interface software;
artificial intelligence and machine learning software for
genome analysis, developing personal treatment strategies
for patients with diagnosed cancer, analyzing, screening,
identifying, quantifying, and interpreting data in the field
of mass spectrometry and next-generation sequencing (NGS);
electronic databases for bioinformatic purposes;
next-generation sequencing (NGS) data processor;
bioinformatics data processor; computer software
35
Business statistical services and modeling with respect to
cancer treatment and cancer diagnosis
42
Computer programming in the medical, pharmaceutical and
biotechnological field; database design; database
maintenance; programming of software for importing and
managing data; information technology services for the
pharmaceutical and healthcare industries; computer
programming for data processing; non-downloadable computer
software; conducting evaluations in the field of
pharmaceuticals; consulting services in the fields of
biotechnology and pharmaceutical research; pharmaceutical
product development and evaluation services; pharmaceutical
research and development; providing medical and scientific
research information in the field of pharmaceuticals and
clinical trials; research and development of pharmaceuticals
for the treatment of cancer; technical research in the field
of pharmaceutical studies; development of platform
technology, namely, cancer immunotherapy platforms for
manufacturing therapeutics; conducting clinical trials in
the field of pharmaceuticals for the treatment and
prevention of cancer; collection of specific molecular and
genomic data for analytical and clinical purposes, for the
treatment of cancer and other diseases and disorders and for
individuals' responses to drug treatments; research and
development of medicines and diagnostic agents for cancer
treatment and cancer diagnosis; providing scientific advice
in the fields of cancer biology, cancer treatment,
pharmaceutical side effects, genomics, cancer medicine and
translational medicine; providing scientific analysis in the
field of next-generation sequencing (NGS) with respect to
the analysis and interpretation of genomic data obtained
from cancer patients; providing an online, non-downloadable
computer software platform for purposes of storing and
providing information about an individual's cancer profile
and genomic changes to enable physicians and healthcare
professionals to optimize treatment in clinical practice;
research and development services in the field of
immunology
44
Medical and pharmaceutical services
Trademark history
| Date | Document number | Area | Entry |
|---|---|---|---|
| May 25, 2022 | 2022/21 Gaz | GB | Rejection |
| December 9, 2021 | 2022/6 Gaz | EM | Registration |
ID: 141646138